Burning Rock Biotech
BNR
28 hedge funds and large institutions have $20.1M invested in Burning Rock Biotech in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 12 reducing their positions, and 6 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.61% less ownership
Funds ownership: 20.83% → 20.22% (-0.61%)
13% less funds holding
Funds holding: 32 → 28 (-4)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
75% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 12
79% less capital inflows, than outflows
Capital inflows: $284K | Capital outflows: $1.32M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lansdowne Partners (UK)
London,
United Kingdom
|
+$191K |
| 2 |
Millennium Management
New York
|
+$53.6K |
| 3 |
EWA LLC
Pittsbugh,
Pennsylvania
|
+$36.2K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$2.7K |
| 5 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$203 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$490K |
| 2 |
Barclays
London,
United Kingdom
|
-$373K |
| 3 |
Invesco
Atlanta,
Georgia
|
-$110K |
| 4 |
BlackRock
New York
|
-$63.3K |
| 5 |
State Street
Boston,
Massachusetts
|
-$63.2K |
BNR Hedge Fund Activity: Q3 2023 in Review
28 of the 6,317 institutional investors tracked by Wall St. Rank reported a position in Burning Rock Biotech (BNR) for Q3 2023, worth a combined $20.1M — down 56% from $46.2M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of BNR and 2 opened new positions — a net loss of 4 holders — while 12 trimmed existing stakes and 3 added.
The largest buyer was Lansdowne Partners (UK), opening a new position worth an estimated $191K. The largest seller was Morgan Stanley, cutting an estimated $490K.
- 28 institutional investors held Burning Rock Biotech (BNR) as of Q3 2023, down from 32 in Q2 2023.
- Funds reported $20.1M of Burning Rock Biotech stock for Q3 2023, down 56% quarter-over-quarter.
- 2 funds opened new Burning Rock Biotech positions in Q3 2023 and 6 closed out, a net change of -4 holders.
- The largest Burning Rock Biotech buyer in Q3 2023 was Lansdowne Partners (UK), an estimated $191K added.
- The largest Burning Rock Biotech seller in Q3 2023 was Morgan Stanley, an estimated $490K sold.
Based on aggregated 13F filings for Q3 2023.